Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

Recruiting now

Conditions studied: Diabetes, Obesity & Overweight, Cushing Syndrome, Metabolic Diseases, Endocrine Diseases, Sarcopenia, Sarcopenic Obesity

In brief

Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population. .

Key facts

Study ID

NCT07703683

Run by

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

People needed

100

Starts

2026-02-19

Expected to finish

2056-12-31

Last updated by the study team

2026-07-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Metabolic or endocrine disease

You may not qualify if…

• Known myopathy
• Systemic steroid use (> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome
• Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol
• History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor

Where it is running

• Cliniques Universitaires Saint-Luc — Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.